Cancer Incidence in Living Liver Donors After Donor Hepatectomy
- PMID: 37667582
- PMCID: PMC10477075
- DOI: 10.3346/jkms.2023.38.e277
Cancer Incidence in Living Liver Donors After Donor Hepatectomy
Abstract
Living liver donors (LLDs) are screened for transmissible diseases including cancer. We investigated the actual cancer incidence of LLDs compared with a matched healthy control group from the general Korean population using data from the Korean National Health Insurance Services (NHIS). A total of 12,372 LLDs who donated a liver graft between 2002 and 2018 were registered in the Korean Network for Organ Sharing. They were compared to a matched healthy control group selected from the Korean NHIS. Cancer diagnosis was identified in 175 LLDs (1.4%) and 1,014 controls (0.8%). Compared to the healthy control group, the incidence rate ratio of liver and thyroid cancer in the LLD group were significantly higher at 18.30 and 1.39, respectively. The incidences of 11 other specified cancers were not different between the two groups. The present study suggests that LLD after donor hepatectomy may require medical surveillance, especially for liver cancer.
Keywords: Liver Transplantation; Living Liver Donors; Malignancy.
© 2023 The Korean Academy of Medical Sciences.
Conflict of interest statement
The authors have no potential conflicts of interest to disclose.
References
-
- Lee O, Kim JM, Kim SJ, Rhu J, Choi GS, Joh JW. Healthy spouses can be considered as living liver donors. World J Surg. 2022;46(6):1474–1484. - PubMed
-
- Choi JY, Kim JH, Kim JM, Kim HJ, Ahn HS, Joh JW. Outcomes of living liver donors are worse than those of matched healthy controls. J Hepatol. 2022;76(3):628–638. - PubMed
-
- Lee JG, Lee KW, Kwon CH, Chu CW, Kim BW, Choi DL, et al. Donor safety in living donor liver transplantation: the Korean organ transplantation registry study. Liver Transpl. 2017;23(8):999–1006. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
